Extracted Antibodies for COVID-19 Treatment: Phase 1 of Human Trials Begin
Jun 03, 2020 AM EDT
Last Monday, the American pharmaceutical company Eli Lilly and Company had carried out human trials for the world's first potential antibody treatment against COVID-19, starring an antibody called LY-CoV555.
